Sign In
Buy ARMP
$7.01
+0.140 (+2.04%)
At Close: Jun 23, 2026
Armata Pharmaceuticals Issues Letter to Shareholders
11:05am, Thursday, 31'st Oct 2019
MARINA DEL REY, Calif., Oct. 31, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage
Armata Pharmaceuticals Announces Receipt of $1.3 million R&D Tax Incentive
11:05am, Monday, 21'st Oct 2019
MARINA DEL REY, Calif., Oct. 21, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage
Armata Pharmaceuticals Strengthens Clinical Team with Appointment of Dr. Heather Dale Jones as Medical Director
11:05am, Wednesday, 16'th Oct 2019
MARINA DEL REY, Calif., Oct. 16, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage
Armata Pharmaceuticals Expands Board of Directors with the Appointment of Research and Development Veteran Todd C. Peterson, Ph.D.
08:05pm, Thursday, 10'th Oct 2019
MARINA DEL REY, Calif., Oct. 10, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage
Video: Lana Del Rey coming to UAE for Abu Dhabi Grand Prix
08:51am, Wednesday, 02'nd Oct 2019
EDM superstar Marshmello also announced
Silicon Valley Giants are Ponying Up $90 Million to Fight California Bill
10:00am, Tuesday, 01'st Oct 2019
Uber, Lyft and DoorDash are prepared to spend $90 million fighting AB 5, a bill that would recognize drivers as employees rather than contractors.
Hollywood’s Unions Tell Their Members That New State Gig Economy Law Won’t Impact Their Loan-Out Companies
12:03am, Friday, 20'th Sep 2019
Hollywood’s unions are assuring members that their loan-out companies will not be negatively impacted by a new California law designed to end the misclassification of gig economy workers as so-call�
Armata Pharmaceuticals to Participate in the Ladenburg Thalmann 2019 Healthcare Conference
11:05am, Thursday, 19'th Sep 2019
MARINA DEL REY, Calif. , Sept. 19, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeut
Editorial: Thank you for backing this newspaper
01:00pm, Sunday, 15'th Sep 2019
Thank you. We asked our readers to raise your voices and tell our state legislators that AB 5 was a bad idea, and to demand newspapers be granted an exemption — because you value local journalism, �
Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa
01:00pm, Thursday, 12'th Sep 2019
MARINA DEL REY, Calif., Sept. 12, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (the "Company" or "Armata"), a clinical-stage biotechnology company focused on precisely targ
Reporter Editorial: Communities need journalism, and journalism needs AB 5 amended
01:00pm, Sunday, 08'th Sep 2019
There may be no more frightening thought than a government that decides who’s going to win and who’s going to lose. That incredible scenario has moved well past the “fear” stage in California,
Cost & Management of Oncology Combination Regimens -
10:53am, Wednesday, 28'th Aug 2019
Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator
Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update
08:05pm, Wednesday, 14'th Aug 2019
MARINA DEL REY, Calif. , Aug. 14, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...
How Much Of Armata Pharmaceuticals, Inc. (NYSEMKT:ARMP) Do Institutions Own?
07:27pm, Friday, 02'nd Aug 2019
The big shareholder groups in Armata Pharmaceuticals, Inc. (NYSEMKT:ARMP) have power over the company. Institutions...
Armata Pharmaceuticals to Provide Corporate Update at the 39th Annual Canaccord Genuity Growth Conference
02:30pm, Thursday, 01'st Aug 2019
MARINA DEL REY, Calif. , Aug. 1, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeuti
